271 related articles for article (PubMed ID: 34359742)
1. Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer.
Hisada Y; Mackman N
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359742
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.
Hisada Y; Mackman N
Curr Opin Hematol; 2019 Sep; 26(5):349-356. PubMed ID: 31261175
[TBL] [Abstract][Full Text] [Related]
3. Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases.
Hisada Y; Sachetto ATA; Mackman N
Immunol Rev; 2022 Nov; 312(1):61-75. PubMed ID: 35708588
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicle Tissue Factor Activity Assay.
Hisada Y; Mackman N
J Vis Exp; 2023 Dec; (202):. PubMed ID: 38224132
[TBL] [Abstract][Full Text] [Related]
5. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus.
Mackman N; Grover SP; Antoniak S
J Thromb Haemost; 2021 Nov; 19(11):2652-2658. PubMed ID: 34418279
[TBL] [Abstract][Full Text] [Related]
7. Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
Hisada Y; Mackman N
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):182-186. PubMed ID: 31808871
[TBL] [Abstract][Full Text] [Related]
8. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
9. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation.
Hell L; Däullary T; Burghart V; Mauracher LM; Grilz E; Moser B; Kramer G; Schmid JA; Ay C; Pabinger I; Thaler J
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804899
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor activity of small and large extracellular vesicles in different diseases.
Sachetto ATA; Archibald SJ; Hisada Y; Rosell A; Havervall S; van Es N; Nieuwland R; Campbell RA; Middleton EA; Rondina MT; Thålin C; Mackman N
Res Pract Thromb Haemost; 2023 Mar; 7(3):100124. PubMed ID: 37012986
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new bead-based assay to measure levels of human tissue factor antigen in extracellular vesicles in plasma.
Archibald SJ; Hisada Y; Bae-Jump VL; Mackman N
Res Pract Thromb Haemost; 2022 Feb; 6(2):e12677. PubMed ID: 35284777
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications.
Koizume S; Miyagi Y
Br J Cancer; 2022 Dec; 127(12):2099-2107. PubMed ID: 36097177
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
Geddings JE; Mackman N
Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
[TBL] [Abstract][Full Text] [Related]
15. Differential biomarker profiles between unprovoked venous thromboembolism and cancer.
Sánchez-López V; Gao L; Ferrer-Galván M; Arellano-Orden E; Elías-Hernández T; Jara-Palomares L; Asensio-Cruz MI; Castro-Pérez MJ; Rodríguez-Martorell FJ; Lobo-Beristain JL; Ballaz-Quincoces A; López-Campos JL; Vila-Liante V; Otero-Candelera R
Ann Med; 2020 Sep; 52(6):310-320. PubMed ID: 32634035
[TBL] [Abstract][Full Text] [Related]
16. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y
Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262
[TBL] [Abstract][Full Text] [Related]
17. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
18. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.
Spiezia L; Campello E; Valle FD; Woodhams B; Simioni P
Clin Chem Lab Med; 2017 Mar; 55(4):484-488. PubMed ID: 27522621
[TBL] [Abstract][Full Text] [Related]
19. Measurement of tissue factor activity in extracellular vesicles from human plasma samples.
Hisada Y; Mackman N
Res Pract Thromb Haemost; 2019 Jan; 3(1):44-48. PubMed ID: 30656275
[TBL] [Abstract][Full Text] [Related]
20. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
